Welcome to XEN® Gel Stent. XEN® is an established treatment option for refractory glaucoma and an outpatient procedure.

The XEN ® Gel Stent creates a small channel in the eye to drain fluid and help lower eye pressure. The XEN ® Gel Stent is tiny—about the length of an eyelash—and it’s placed just …

The XEN ® Gel Stent is indicated for the treatment of primary open angle glaucoma (POAG) where previous medical treatment failed and for patients with pseudoexfoliative glaucoma …

The XEN gel stent procedure is a minimally invasive glaucoma surgery where a small, flexible tube (the stent) is inserted into the eye to create a new drainage pathway, reducing eye …

The XEN ® Glaucoma Treatment System (XEN ® 45 Gel Stent preloaded into a XEN ® Injector) is indicated for the management of refractory glaucomas, including cases where previous …

The Xen gel implant is a microstent that can lowers IOP via subconjunctival drainage without the tissue disruption of a trabeculectomy or traditional glaucoma drainage implant. [4] [15] FDA …

The XEN gel stent (AbbVie Inc., Chicago, IL, USA) was originally developed as an ab interno procedure that reduces IOP by draining aqueous fluid from the anterior chamber into the …

The Xen Gel Stent is inserted through a clear corneal incision with one end implanted in the subconjunctival space and the other in the anterior chamber to facilitate aqueous outflow for …

Our results confirmed that XEN is effective in lowering both IOP and NOAM till 48 months after surgery. It is noteworthy that XEN implantation leads to higher needling rate, compared to …

XEN Gel Stent (Allergan, an AbbVie company) is an FDA-approved minimally invasive bleb surgery device. XEN Gel Stent preloaded into a XEN Injector is indicated for the management …